Drugs
Rivaroxaban
3 articles published between August 20, 2026 and November 13, 2026.
Covered in Body and Science.
WHAT THE STUDY ACTUALLY SAYSIn an 18,883-patient trial, aspirin failed a non-inferiority test against warfarin and rivaroxaban for preventing clots — but the anticoagulants in turn were not safer than aspirin on bleeding.
3 min read
WHAT THE STUDY ACTUALLY SAYSThe TRACK trial was stopped early for futility. The blood thinner failed to reduce a composite of cardiovascular events, while major bleeding rose by half. Bayer, which makes the drug, was a listed collaborator.
3 min read
WHAT THE STUDY ACTUALLY SAYSObservational studies had linked proton pump inhibitors to fractures, dementia, kidney disease and more. A randomised trial collected all of those outcomes and found only enteric infections.
4 min read
This page indexes this newspaper’s reporting on Rivaroxaban. It is not a medical reference entry, and nothing here is medical advice. See our editorial standards.